| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 04/04/2002 | US20020039758 Fermentative production of valuable compounds on an industrial scale using chemically defined media |
| 04/04/2002 | US20020039585 Mutants of streptococcal toxin c and methods of use |
| 04/04/2002 | US20020039580 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification |
| 04/04/2002 | DE10133162A1 Für das thyA-Gen kodierende Nukleotidsequenzen For the thyA gene coding nucleotide sequences |
| 04/04/2002 | DE10108838A1 Neue für das hisC2-Gen kodierende Nukleotidsequenzen New coding for the hisC2 gene nucleotide sequences |
| 04/04/2002 | DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines) |
| 04/04/2002 | DE10044831A1 Verbessertes Verfahren zur mikrobiellen Herstellung von L-Serin sowie ein dazu geeigneter genetisch veränderter Mikroorganismus An improved method for the microbial production of L-serine as well as a thereto suitable genetically modified microorganism |
| 04/04/2002 | DE10043944A1 Verfahren zur Herstellung lignilolytischer Enzyme mittels holzbewohnender Pilze aus der Ordnung Agaricales Process for the preparation lignilolytischer enzymes via holzbewohnender fungi belonging to the order Agaricales |
| 04/04/2002 | CA2436251A1 Liquid yeast activator, solid yeast activator and manufacturing method thereof, and manufacturing method of fermented product |
| 04/04/2002 | CA2424004A1 Recombinant bcg vaccines for the prevention and treatment of cancer |
| 04/04/2002 | CA2423991A1 Pumpcn compositions and uses thereof |
| 04/04/2002 | CA2423955A1 Kini-3 motor protein and methods for its use |
| 04/04/2002 | CA2423953A1 Hydrolases |
| 04/04/2002 | CA2423942A1 Human ion-exchanger proteins and polynucleotides encoding the same |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423701A1 Oxidoreductases |
| 04/04/2002 | CA2423694A1 Transferases |
| 04/04/2002 | CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | CA2423588A1 Improved vaccines for proliferative ileitis and methods of making and using the same |
| 04/04/2002 | CA2423446A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2422530A1 Human drug metabolizing enzymes |
| 04/04/2002 | CA2421680A1 Antibodies for human cytochrome p450 2d6 |
| 04/04/2002 | CA2421620A1 Promoter sequences |
| 04/03/2002 | EP1193314A1 Lipase and use of same for improving doughs and baked products |
| 04/03/2002 | EP1193311A1 Method for stimulating the mating of microorganisms in liquid medium |
| 04/03/2002 | EP1193272A1 Single-chain insulin analogs |
| 04/03/2002 | EP1193271A2 Compositions and methods for protein structural determinations |
| 04/03/2002 | EP1193249A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 04/03/2002 | EP1192280A1 Synthetic ligation reassembly in directed evolution |
| 04/03/2002 | EP1192278A1 48 human secreted proteins |
| 04/03/2002 | EP1192263A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 1 promoter and terminator |
| 04/03/2002 | EP1192259A1 Tankyrase2 materials and methods |
| 04/03/2002 | EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods |
| 04/03/2002 | EP1192257A2 Human regulators of intracellular phosphorylation |
| 04/03/2002 | EP1192256A1 Global regulators of bacterial pathogenic genes; bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 04/03/2002 | EP1192254A1 Helical polypeptide zalpha29 |
| 04/03/2002 | EP1192252A2 Secreted protein zacrp4 |
| 04/03/2002 | EP1192251A1 Human sel-10 polypeptides and polynucleotides that encode them |
| 04/03/2002 | EP1192250A2 Human rna metabolism proteins (rmep) |
| 04/03/2002 | EP1192249A1 47 human secreted proteins |
| 04/03/2002 | EP1192242A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 04/03/2002 | EP1192176A1 49 human secreted proteins |
| 04/03/2002 | EP1192174A2 Antagonists of bmp and tgf beta signalling pathways |
| 04/03/2002 | EP1192171A1 48 human secreted proteins |
| 04/03/2002 | EP1192147A1 Mycolactone and related compounds, compositions and methods of use |
| 04/03/2002 | EP1191940A1 Tumor necrosis factor receptor 5 |
| 04/03/2002 | EP0935603B1 Gene synthesis method |
| 04/03/2002 | EP0900283B1 MICROBIAL 11alpha-HYDROXYLATION OF STEROIDS |
| 04/03/2002 | CN1343253A Expression of proteolytic enzymes in koji mold in presence of carbon sources |
| 04/03/2002 | CN1343221A Polypeptide variants with altered effector function |
| 04/03/2002 | CN1343136A Vessel for mixing cell lysate |
| 04/03/2002 | CN1343124A Bacterial membrane fractions with adjuvant effect |
| 04/03/2002 | CN1342752A Process for transforming ganoderma by agrobacterium to mediate foreign gene |
| 04/03/2002 | CN1342751A Technique for culturing edible fungus with bags |
| 04/03/2002 | CN1082092C Process for producing substance |
| 04/03/2002 | CN1082089C Fermentation technology of xylaria nigripes |
| 04/03/2002 | CN1082031C Method of biotreatment for solid materials in nonstirred surface bioreactor |
| 04/02/2002 | USH2019 Identifying compounds that bind and/or inhibit the hi1648 protein. |
| 04/02/2002 | US6365757 Culturing tissues of taxus wallichiania; isolation by partitioning the culture product residue, obtained by polar solvent extraction; desolventizing between water and chlorinated solvents; evaporation; chromotography; adsorption; |
| 04/02/2002 | US6365725 DNA coding for a human vasoconstrictive peptide and use thereof |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365714 Amino acid sequence of a polypeptide; antiinflammatory agents; antiproliferative agents; antiapoptotic agents |
| 04/02/2002 | US6365712 Isolated soluble cd antigen; diagnosis and treatment of related disorders |
| 04/02/2002 | US6365711 Methods and reagents for modulating TGF-β superfamily signalling |
| 04/02/2002 | US6365569 To protect animals from diseases caused by parasitic helminths |
| 04/02/2002 | US6365410 Culturing microorganism with a heterologous mutator gene having an increased mutation rate for at least 20 doublings under selective conditions, then restoring resultant microorganism to wild type mutation rate; biosynthesis |
| 04/02/2002 | US6365409 Regulated gene expression in yeast |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365397 Bacterial culture which degrades methyl-tert-butyl ether to carbon dioxide |
| 04/02/2002 | US6365396 Parasite-derived resistance |
| 04/02/2002 | US6365391 Isolated human serine protease, nucleic acid molecules encoding human serine protease, and uses thereof |
| 04/02/2002 | US6365390 Phenolic acid esterases, coding sequences and methods |
| 04/02/2002 | US6365389 Human protein kinase H2LAU20 |
| 04/02/2002 | US6365388 Biotin biosynthetic genes |
| 04/02/2002 | US6365387 fabG |
| 04/02/2002 | US6365386 Polynucleotide which codes for enzyme that converts beta-carotene to astaxanthin |
| 04/02/2002 | US6365384 Method for disposing waste |
| 04/02/2002 | US6365381 Producing (s)-4-hydroxy-2-ketoglutaric acid and compounds which are formed by biosynthesis from this precursor using recombinant microorganism carrying a recombinant dna harboring this acid aldolase gene, sugar and glyoxylic acid |
| 04/02/2002 | US6365376 Nucleic acids isolated from brevibacterium which encode transcription factor, caprolactone hydrolase, cyclohexanone monooxygenase, 6-hydroxyhexanoic acid dehydrogenase, cyclohexanol dehydrogenase, and regulatory protein |
| 04/02/2002 | US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365365 Method of determining whether an agent modulates glycosyl sulfotransferase-3 |
| 04/02/2002 | US6365361 Method for identifying or screening agonist and antagonist to PPAR |
| 04/02/2002 | US6365358 Polypeptide of defined amino acid sequence; diagnosis, prevention and treatment of cancer, developmental, autoimmune and nervous system disorders; anticarcinogenic agents; antiinflammatory agents |
| 04/02/2002 | US6365350 Method of DNA sequencing |
| 04/02/2002 | US6365207 Use of liquid carbohydrate fermentation product in foods |
| 04/02/2002 | US6365160 Polyprotein construct comprising amino acid sequences fused directly or indirectly together, each being sequence of early open reading frame protein of papillomavirus, or immunogenic variant or non-full length deletion mutant thereof |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | US6365158 Immunizing avian host with purified recombinant fusion protein comprising non-toxin protein sequence and portion of clostridium difficile toxin b sequence so as to generate neutralizing antitoxin |
| 04/02/2002 | US6365127 Isolation of a gene encoding human thyrotropin beta subunit |
| 04/02/2002 | CA2124214C Materials and methods for biosynthesis of serine and serine-related products |
| 04/02/2002 | CA2086835C Tissue plasminogen activator variants with decreased clearance |
| 03/29/2002 | CA2340303A1 Rna-binding protein |
| 03/28/2002 | WO2002024936A1 Process for the fermentative preparation of d-pantothenic acid using coryneform bacteria |
| 03/28/2002 | WO2002024930A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 03/28/2002 | WO2002024926A1 Talaromyces xylanases |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024923A1 Polypeptide having phospholipase a2 actiivty |
| 03/28/2002 | WO2002024920A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |